BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15048958)

  • 1. Using urbanization profiles to assess screening performance.
    Boon ME; Kok LP
    Diagn Cytopathol; 2004 Apr; 30(4):243-6. PubMed ID: 15048958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Re: the editorial in number 4, volume 28, 2008. "Cervical cancer control in Colombia: achievements and challenges of cytology based programs"].
    Calvache AE
    Biomedica; 2009 Mar; 29(1):161-2; author reply 162-3. PubMed ID: 19753849
    [No Abstract]   [Full Text] [Related]  

  • 3. Urbanization and the incidence of abnormalities of squamous and glandular epithelium of the cervix.
    Boon ME; van Ravenswaay Claasen HH; van Westering RP; Kok LP
    Cancer; 2003 Feb; 99(1):4-8. PubMed ID: 12589639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.
    Wiener HG; Klinkhamer P; Schenck U; Arbyn M; Bulten J; Bergeron C; Herbert A
    Cytopathology; 2007 Apr; 18(2):67-78. PubMed ID: 17397490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National registry of cervical cytologic diagnoses in The Netherlands.
    Vooijs GP; Casparie-van Velsen IA; Peters FA; Beck HL
    Acta Cytol; 1989; 33(6):825-30. PubMed ID: 2588915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer screening from the public health perspective.
    Steiner C
    Acta Cytol; 1989; 33(4):471-4. PubMed ID: 2750437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cytology quality assurance in Washington State.
    Taylor V; Frost F
    Acta Cytol; 1992; 36(2):246-50. PubMed ID: 1543009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assessment in the age of machine-aided cervical cytology screening.
    Renshaw AA
    Cancer; 2004 Dec; 102(6):345-7. PubMed ID: 15540251
    [No Abstract]   [Full Text] [Related]  

  • 9. Random rescreening of cytologic smears: a practical and effective component of quality assurance programs in both large and small cytology laboratories.
    Krieger P; Naryshkin S
    Acta Cytol; 1994; 38(3):291-8. PubMed ID: 8191815
    [No Abstract]   [Full Text] [Related]  

  • 10. European guidelines on cervical screening.
    Smith JH; Desai MS
    Cytopathology; 2007 Aug; 18(4):211-2. PubMed ID: 17635160
    [No Abstract]   [Full Text] [Related]  

  • 11. Interlaboratory reproducibility of atypical glandular cells of undetermined significance: a national survey.
    Confortini M; Di Bonito L; Carozzi F; Ghiringhello B; Montanari G; Parisio F; Prandi S;
    Cytopathology; 2006 Dec; 17(6):353-60. PubMed ID: 17168918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An operative model: verification of the quality of the screening Pap test ].
    Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
    Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
    [No Abstract]   [Full Text] [Related]  

  • 13. European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology.
    Arbyn M; Herbert A; Schenck U; Nieminen P; Jordan J; Mcgoogan E; Patnick J; Bergeron C; Baldauf JJ; Klinkhamer P; Bulten J; Martin-Hirsch P
    Cytopathology; 2007 Jun; 18(3):133-9. PubMed ID: 17573762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cervical smears taken by physicians' assistants are of lesser quality than smears taken by family physicians, but almost as good as the national average].
    van Rijswijk A
    Ned Tijdschr Geneeskd; 2000 Feb; 144(8):399. PubMed ID: 10703599
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates.
    Goldzweig CL; Parkerton PH; Washington DL; Lanto AB; Yano EM
    Am J Manag Care; 2004 Apr; 10(4):265-72. PubMed ID: 15124503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An effective and affordable cervical carcinoma screening programme for Sri Lanka.
    Kumarasinghe MP
    Ceylon Med J; 1999 Dec; 44(4):156-8. PubMed ID: 10895264
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience in managing a large-scale rescreening of Papanicolaou smears and the pros and cons of measuring proficiency with visual and written examinations.
    Rube IF
    Acta Cytol; 1989; 33(4):479-83. PubMed ID: 2546349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV testing for cervical cancer screening in Croatia.
    Grce M; Grahovac B; Rukavina T; Vrdoljak-Mozetic D; Glavas-Obrovac L; Kaliterna V; Zele-Starcević L
    Coll Antropol; 2007 Apr; 31 Suppl 2():67-71. PubMed ID: 17598507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality control in cytologic screening.
    Cecchini S; Grazzini G; Bonardi R; Ciatto S
    Acta Cytol; 1993; 37(3):436. PubMed ID: 8498145
    [No Abstract]   [Full Text] [Related]  

  • 20. Canadian experience in cytology proficiency testing.
    Thompson DW
    Acta Cytol; 1989; 33(4):484-6. PubMed ID: 2546350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.